UCB Celltech

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Completed	A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects Healthy Volunteers	Phase 1	2016-03-04
Terminated	UCB Proof of Concept Study in Patients With Primary Sjögren's Syndrome Primary Sjögren's Syndrome	Phase 2	2015-10-01
Completed	Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis	Phase 2	2015-04-01
Completed	Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy S Healthy Volunteers	Phase 1	2014-08-01
Completed	A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers Healthy	Phase 1	2014-07-01
Completed	Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis Psoriatic Arthritis	Phase 1	2014-05-01
Completed	A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With Psoriasis Mild to Moderate Psoriasis	Phase 1	2012-11-01
Terminated	The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents Crohn's Disease	Phase 2	2009-04-01